Skip to main content

Kevin DeGeeter

Analyst

Oppenheimer

Analyst

Ladenburg Thalmann & Company

Equibles does not estimate personal net worth.

About Kevin DeGeeter

Kevin DeGeeter is recorded as Analyst at Oppenheimer and Analyst at Ladenburg Thalmann & Company. Kevin DeGeeter has spoken on 1 earnings call across 1 company, most recently for Vericel Corp on May 5, 2021. The companies whose calls Kevin DeGeeter spoke on are classified in the Healthcare sector.

Kevin DeGeeter on recent calls

“With regard to NexoBrid, did I hear correctly that the FDA has requested additional CMC information from MediWound? If so, can you provide some context around that statement?”
Analyst — Oppenheimer, Vericel Corp Q1 FY2021 Earnings Call ·

Affiliation history

  • Oppenheimer

    Analyst

    Source not stated

    Current
  • Ladenburg Thalmann & Company

    Analyst

    Source not stated

    Current

Company network

Recent activity